0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      G-quadruplexes mark alternative lengthening of telomeres

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          About 10–15% of all human cancer cells employ a telomerase-independent recombination-based telomere maintenance method, known as alternative lengthening of telomere (ALT), of which the full mechanism remains incompletely understood. While implicated in previous studies as the initiating signals for ALT telomere repair, the prevalence of non-canonical nucleic acid structures in ALT cancers remains unclear. Extending earlier reports, we observe higher levels of DNA/RNA hybrids (R-loops) in ALT-positive (ALT+) compared to telomerase-positive (TERT+) cells. Strikingly, we observe even more pronounced differences for an associated four-stranded nucleic acid structure, G-quadruplex (G4). G4 signals are found at the telomere and are broadly associated with telomere length and accompanied by DNA damage markers. We establish an interdependent relationship between ALT-associated G4s and R-loops and confirm that these two structures can be spatially linked into unique structures, G-loops, at the telomere. Additionally, stabilization of G4s and R-loops cooperatively enhances ALT-activity. However, co-stabilization at higher doses resulted in cytotoxicity in a synergistic manner. Nuclear G4 signals are significantly and reproducibly different between ALT+ and TERT+ low-grade glioma tumours. Together, we present G4 as a novel hallmark of ALT cancers with potential future applications as a convenient biomarker for identifying ALT+ tumours and as therapeutic targets.

          Graphical Abstract

          Graphical abstract

          ALT+ cells promote a telomeric environment that leads to increased formation of G-quadruplexes and R-loops. Co-formation of G-quadruplexes and R-loops results in special structures, G-loops, which are postulated to facilitate the ALT recombination process.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          CellProfiler 3.0: Next-generation image processing for biology

          CellProfiler has enabled the scientific research community to create flexible, modular image analysis pipelines since its release in 2005. Here, we describe CellProfiler 3.0, a new version of the software supporting both whole-volume and plane-wise analysis of three-dimensional (3D) image stacks, increasingly common in biomedical research. CellProfiler’s infrastructure is greatly improved, and we provide a protocol for cloud-based, large-scale image processing. New plugins enable running pretrained deep learning models on images. Designed by and for biologists, CellProfiler equips researchers with powerful computational tools via a well-documented user interface, empowering biologists in all fields to create quantitative, reproducible image analysis workflows.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.

            Glioblastoma multiforme (GBM) is a lethal brain tumour in adults and children. However, DNA copy number and gene expression signatures indicate differences between adult and paediatric cases. To explore the genetic events underlying this distinction, we sequenced the exomes of 48 paediatric GBM samples. Somatic mutations in the H3.3-ATRX-DAXX chromatin remodelling pathway were identified in 44% of tumours (21/48). Recurrent mutations in H3F3A, which encodes the replication-independent histone 3 variant H3.3, were observed in 31% of tumours, and led to amino acid substitutions at two critical positions within the histone tail (K27M, G34R/G34V) involved in key regulatory post-translational modifications. Mutations in ATRX (α-thalassaemia/mental retardation syndrome X-linked) and DAXX (death-domain associated protein), encoding two subunits of a chromatin remodelling complex required for H3.3 incorporation at pericentric heterochromatin and telomeres, were identified in 31% of samples overall, and in 100% of tumours harbouring a G34R or G34V H3.3 mutation. Somatic TP53 mutations were identified in 54% of all cases, and in 86% of samples with H3F3A and/or ATRX mutations. Screening of a large cohort of gliomas of various grades and histologies (n = 784) showed H3F3A mutations to be specific to GBM and highly prevalent in children and young adults. Furthermore, the presence of H3F3A/ATRX-DAXX/TP53 mutations was strongly associated with alternative lengthening of telomeres and specific gene expression profiles. This is, to our knowledge, the first report to highlight recurrent mutations in a regulatory histone in humans, and our data suggest that defects of the chromatin architecture underlie paediatric and young adult GBM pathogenesis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Alternative lengthening of telomeres: models, mechanisms and implications.

              Unlimited cellular proliferation depends on counteracting the telomere attrition that accompanies DNA replication. In human cancers this usually occurs through upregulation of telomerase activity, but in 10-15% of cancers - including some with particularly poor outcome - it is achieved through a mechanism known as alternative lengthening of telomeres (ALT). ALT, which is dependent on homologous recombination, is therefore an important target for cancer therapy. Although dissection of the mechanism or mechanisms of ALT has been challenging, recent advances have led to the identification of several genes that are required for ALT and the elucidation of the biological significance of some phenotypic markers of ALT. This has enabled development of a rapid assay of ALT activity levels and the construction of molecular models of ALT.
                Bookmark

                Author and article information

                Contributors
                Journal
                NAR Cancer
                NAR Cancer
                narcancer
                NAR Cancer
                Oxford University Press
                2632-8674
                September 2021
                21 July 2021
                21 July 2021
                : 3
                : 3
                : zcab031
                Affiliations
                Faculty of Pharmaceutical Sciences, University of British Columbia , Vancouver, V6T 1Z3, Canada
                Terry Fox Laboratory, BC Cancer , Vancouver, V5Z 1L3, Canada
                Faculty of Pharmaceutical Sciences, University of British Columbia , Vancouver, V6T 1Z3, Canada
                Faculty of Pharmaceutical Sciences, University of British Columbia , Vancouver, V6T 1Z3, Canada
                Institut de Chimie Moléculaire, ICMUB CNRS UMR 6302 , UBFC Dijon, 21078 Dijon, France
                Department of Pathology and Laboratory Medicine, University of British Columbia , Vancouver, V6T 2B5 Canada
                Terry Fox Laboratory, BC Cancer , Vancouver, V5Z 1L3, Canada
                Faculty of Pharmaceutical Sciences, University of British Columbia , Vancouver, V6T 1Z3, Canada
                Author notes
                To whom correspondence should be addressed. Tel: +1 604 827 3314; Fax: +1 604 822 3035; Email: judy.wong@ 123456ubc.ca
                Author information
                https://orcid.org/0000-0002-3056-9295
                https://orcid.org/0000-0002-8514-9861
                https://orcid.org/0000-0001-5572-4143
                Article
                zcab031
                10.1093/narcan/zcab031
                8294677
                34316718
                ff6f4e6a-8907-4a89-b5c1-8d4e1f0bb6cd
                © The Author(s) 2021. Published by Oxford University Press on behalf of NAR Cancer.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@ 123456oup.com

                History
                : 05 July 2021
                : 29 June 2021
                : 08 April 2021
                Page count
                Pages: 14
                Funding
                Funded by: UBC Faculty of Pharmaceutical Sciences Research Reinvestment Funds;
                Categories
                AcademicSubjects/SCI00030
                AcademicSubjects/SCI00980
                AcademicSubjects/SCI01060
                AcademicSubjects/SCI01140
                AcademicSubjects/SCI01180
                Standard Article

                Comments

                Comment on this article